LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
24h
Actuel
Min
3.7
Max
3.74
Recommandations | Achat |
|---|---|
Prévisions sur 12 Mois | +187.43% upside |
Prochains Résultats | 27 mars 2026 |
|---|
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
15 déc. 2025, 16:30 UTC
Fortress Biotech Rises After FDA Accepts Application for Menkes Treatment
DJ
Lire
1 oct. 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Lire
10 mars 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Lire
10 mars 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Lire
10 mars 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Lire
10 mars 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Lire
10 mars 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Lire
10 mars 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lire
10 mars 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lire
Variation de prix
By TipRanks
Prévisions sur 12 Mois
Moyen 10.75 USD 187.43%
Haut 17 USD
Bas 4.5 USD
Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.
By TipRanks
Achat
2 ratings
2
Achat
0
Maintien
0
Vente
Basé sur 2 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.
$